4
Total investments
1
Early stage
0
Mid stage
1
Late stage
15y
Years active
Portfolio
3 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Board Member
May 2020
Elekta Kaiku works with Life sciences partners to provide personalized cancer care via advanced digital patient monitoring and support. Our co-created modules provide the most personalized patient support and optimize the treatment journey whilst generating robust real-world data (RWD) for use in post-marketing commitments. As a clinical trials digital companion Elekta Kaiku captures the outcomes that matter to patients when bringing new targeted therapies to market.
Board Member
Oct 2017
OnDosis Dosage Manager delivers flexible and individualized dosing of oral medicines formulated as pellets, granules, mini tablets or powders. We are writing a new chapter in personalized medicine, and enable closed loop disease management. OnDosis is currently developing products for individualized dosing in diseases with a significant burden on patients and healthcare such as ADHD, pain management and immunosuppression for organ transplants. Hundreds of thousands of patients with these conditions could be helped by improved dosing, ultimately leading to improving health care outcomes.
OnDosis was founded as a spin-out from AstraZeneca in 2017 and is headquartered in Gothenburg, Sweden.
Experience · 5 entries
All (5)
Investments (4)
Board (4)
2020
Board Member
May 2020
Elekta Kaiku works with Life sciences partners to provide personalized cancer care via advanced digital patient monitoring and support. Our co-created modules provide the most personalized patient support and optimize the treatment journey whilst generating robust real-world data (RWD) for use in post-marketing commitments. As a clinical trials digital companion Elekta Kaiku captures the outcomes that matter to patients when bringing new targeted therapies to market.
2017
Board Member
Oct 2017
OnDosis Dosage Manager delivers flexible and individualized dosing of oral medicines formulated as pellets, granules, mini tablets or powders. We are writing a new chapter in personalized medicine, and enable closed loop disease management. OnDosis is currently developing products for individualized dosing in diseases with a significant burden on patients and healthcare such as ADHD, pain management and immunosuppression for organ transplants. Hundreds of thousands of patients with these conditions could be helped by improved dosing, ultimately leading to improving health care outcomes.
OnDosis was founded as a spin-out from AstraZeneca in 2017 and is headquartered in Gothenburg, Sweden.
2013
Principal
Jan 2013
Boston Consulting Group partners with leaders in business and society to tackle their most important challenges and capture their greatest opportunities. BCG was the pioneer in business strategy when it was founded in 1963. Today, we work closely with clients to embrace a transformational approach aimed at benefiting all stakeholders—empowering organizations to grow, build sustainable competitive advantage, and drive positive societal impact.
Our diverse, global teams bring deep industry and functional expertise and a range of perspectives that question the status quo and spark change. BCG delivers solutions through leading-edge management consulting, technology and design, and corporate and digital ventures.
We work in a uniquely collaborative model across the firm and throughout all levels of the client organization, fueled by the goal of helping our clients thrive and enabling them to make the world a better place.
BCG Privacy Policy: https://www.bcg.com/about/privacy-policy.aspx
2011
Board member
Dec 2011
The Swedish Medical Association (Sveriges Läkarförbund) is the union and professional organisation for medical practitioners. Important issues dealt with include doctors’ work environment, salaries, working hours, training and research. The SMA also has key role to play in influencing the development of healthcare in Sweden. Over 90 per cent of Sweden’s doctors belong to the SMA.
Investment activity
2011–2020 · 4 investments
Recent (last 2 years)Earlier
